MAZE vs MDT · rev $20.0M vs P/E 21, rev $36.36B
Maze Therapeutics, Inc. Common Stock (MAZE) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Medtronic PLC (MDT) is a medical devices company listed on US.
Latest reported MAZE revenue for 2026-06-30 was $20.0M. Net income was -$68.9M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. MAZE currently screens at market cap $525.3M.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
MAZE currently screens at market cap $525.3M. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the MAZE and MDT stock pages for the full models.
Not investment advice.